Dow Inc/ US2605571031 /
2024-03-28 5:25:11 PM | Chg. -0.27 | Volume | Bid5:25:13 PM | Ask5:25:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
57.88USD | -0.46% | 1.28 mill. Turnover: 57.98 mill. |
57.87Bid Size: 300 | 57.88Ask Size: 1,100 | 40.7 bill.USD | 4.83% | 70.67 |
GlobeNewswire
02-13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
01-22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
2023-11-16
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
2023-10-11
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
2023-09-06
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
2021-11-17
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year